Logo image of NNE

NANO NUCLEAR ENERGY INC (NNE) Stock Fundamental Analysis

NASDAQ:NNE - US63010H1086 - Common Stock

32.61 USD
+0.07 (+0.22%)
Last: 9/2/2025, 8:22:11 PM
32.54 USD
-0.07 (-0.21%)
After Hours: 9/2/2025, 8:22:11 PM
Fundamental Rating

3

NNE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 92 industry peers in the Electrical Equipment industry. No worries on liquidiy or solvency for NNE as it has an excellent financial health rating, but there are worries on the profitability. NNE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NNE has reported negative net income.
In the past year NNE has reported a negative cash flow from operations.
NNE Yearly Net Income VS EBIT VS OCF VS FCFNNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -14.90%, NNE is in line with its industry, outperforming 57.61% of the companies in the same industry.
NNE has a better Return On Equity (-15.25%) than 60.87% of its industry peers.
Industry RankSector Rank
ROA -14.9%
ROE -15.25%
ROIC N/A
ROA(3y)-53.75%
ROA(5y)N/A
ROE(3y)-56.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NNE Yearly ROA, ROE, ROICNNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NNE Yearly Profit, Operating, Gross MarginsNNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for NNE has been increased compared to 1 year ago.
NNE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NNE Yearly Shares OutstandingNNE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
NNE Yearly Total Debt VS Total AssetsNNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10M 20M 30M

2.2 Solvency

NNE has an Altman-Z score of 155.71. This indicates that NNE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 155.71, NNE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
NNE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 155.71
ROIC/WACCN/A
WACCN/A
NNE Yearly LT Debt VS Equity VS FCFNNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

NNE has a Current Ratio of 73.00. This indicates that NNE is financially healthy and has no problem in meeting its short term obligations.
NNE's Current ratio of 73.00 is amongst the best of the industry. NNE outperforms 100.00% of its industry peers.
A Quick Ratio of 73.00 indicates that NNE has no problem at all paying its short term obligations.
NNE's Quick ratio of 73.00 is amongst the best of the industry. NNE outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 73
Quick Ratio 73
NNE Yearly Current Assets VS Current LiabilitesNNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

NNE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -184.51%.
EPS 1Y (TTM)-184.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NNE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -55.99% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-178.03%
EPS Next 2Y-70.89%
EPS Next 3Y-55.99%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NNE Yearly Revenue VS EstimatesNNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2M 4M 6M 8M 10M
NNE Yearly EPS VS EstimatesNNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NNE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NNE Price Earnings VS Forward Price EarningsNNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NNE Per share dataNNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

A cheap valuation may be justified as NNE's earnings are expected to decrease with -55.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-70.89%
EPS Next 3Y-55.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NNE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NANO NUCLEAR ENERGY INC

NASDAQ:NNE (9/2/2025, 8:22:11 PM)

After market: 32.54 -0.07 (-0.21%)

32.61

+0.07 (+0.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)12-29 2025-12-29
Inst Owners22.62%
Inst Owner Change37.85%
Ins Owners1.61%
Ins Owner Change0%
Market Cap1.36B
Analysts82.5
Price Target36.72 (12.6%)
Short Float %25.93%
Short Ratio2.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-257.36%
Min EPS beat(2)-527.06%
Max EPS beat(2)12.35%
EPS beat(4)3
Avg EPS beat(4)-93.95%
Min EPS beat(4)-527.06%
Max EPS beat(4)99.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-26.03%
PT rev (3m)-24.21%
EPS NQ rev (1m)-2.78%
EPS NQ rev (3m)-37.04%
EPS NY rev (1m)-85.35%
EPS NY rev (3m)-187.84%
Revenue NQ rev (1m)-100%
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-96.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.99
P/tB 6.24
EV/EBITDA N/A
EPS(TTM)-0.96
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS0
BVpS5.44
TBVpS5.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.9%
ROE -15.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.75%
ROA(5y)N/A
ROE(3y)-56.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 73
Quick Ratio 73
Altman-Z 155.71
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-184.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.68%
EPS Next Y-178.03%
EPS Next 2Y-70.89%
EPS Next 3Y-55.99%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-321.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-105.09%
EBIT Next 3Y-83.28%
EBIT Next 5YN/A
FCF growth 1Y-162.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.85%
OCF growth 3YN/A
OCF growth 5YN/A